Skip to main content

Table 3 Univariate and multivariate analyses of OS

From: The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy

Characteristic

Parameter

Univariate analysis

Multivariate analysis

HR(95% CI)

P

HR(95% CI)

P

Gender

Female / Male

0.712 (0.492–1.032)

0.073

–

NI

Age (years)

<60/ ≥60

1.570 (1.083–2.277)

0.017

1.492 (0.994–2.240)

0.054

NE(×109/L)

<7/≥7

1.764 (1.171–2.657)

0.007

1.080 (0.620–1.883)

0.785

LY(×109/L)

<4/≥4

0.788 (0.250–2.482)

0.684

–

NI

HGB(g/L)

<100/≥100

0.869 (0.600–1.258)

0.458

–

NI

PLT(×109/L)

<300/≥300

1.012 (0.699–1.466)

0.948

–

NI

ALT(U/L)

<40/≥40

1.424 (0.894–2.270)

0.137

–

NI

AST(U/L)

<45/≥45

1.279 (0.825–1.983)

0.272

–

NI

ALP(U/L)

<100/≥100

1.171 (0.680–2.017)

0.568

–

NI

GGT(U/L)

<50/≥50

0.953 (0.545–1.664)

0.867

–

NI

ALB(g/L)

<35/≥35

0.976 (0.629–1.514)

0.914

–

NI

TBIL (mmol/L)

<20.5/≥20.5

1.088 (0.701–1.688)

0.706

–

NI

IBIL (mmol/L)

<15/≥15

1.493 (1.030–2.166)

0.035

1.345 (0.895–2.021)

0.154

CRP (mg/L)

<8/≥8

1.189 (0.779–1.814)

0.422

–

NI

Tumor

differentiation

high/ moderate / poor

2.029 (1.421–2.895)

<0.001

1.669 (1.126–2.476)

0.011

Tumor size (cm)

<2/≥2

1.082 (0.837–1.397)

0.548

–

NI

Macrovascular Invision

Absent/Present

1.998 (1.010–3.954)

0.047

1.521 (0.639–3.621)

0.344

Microvascular Invision

Absent/Present

1.592 (1.080–2.347)

0.019

1.098 (0.708–1.703)

0.678

LN metastasis

Absent/Present

1.545 (1.066–2.240)

0.022

0.640 (0.276–1.487)

0.299

TNM Stage

IA/IB/IIA/IIB/III

1.208 (1.051–1.388)

0.008

1.035 (0.777–1.379)

0.814

CEA (μg/L)

<5/≥5

1.356 (1.030–2.289)

0.035

1.172 (0.771–1.283)

0.457

CA199(U/mL)

<35/≥35

2.075 (1.289–3.339)

0.003

1.250 (0.745–2.096)

0.398

Chemotherapy

Absent/Present

0.816 (0.562–1.186)

0.286

–

NI

LNMS

N0/N1/N2

1.574 (1.199–2.067)

0.001

1.786 (0.882–3.618)

0.107

PLNR

≤0.167/>0.167

1.367 (0.870–2.150)

0.176

–

NI

NLR

≤3.32/>3.32

1.599 (1.104–2.317)

0.013

0.820 (0.399–1.683)

0.588

dNLR

≤1.94/>1.94

1.451 (1.002–2.101)

0.049

0.894 (0.478–1.673)

0.726

PLR

≤99.02/>99.02

1.389 (0.676–2.853)

0.371

–

NI

PI

0 / 1 / 2

1.216 (0.906–1.633)

0.193

–

NI

PNI

0 / 1

1.063 (0.693–1.632)

0.778

–

NI

mGPS

0/1/2

0.996 (0.784–1.264)

0.971

–

NI

NLR-PI

1 / 2 / 3

1.570 (1.192–2.068)

0.001

1.684 (1.015–2.796)

0.044

  1. NE Neutrophilic granulocyte, LY Lymphocyte, GGT Glutamyltranspeptidase, ALP Alkaline phosphatase, LNMS Lymph node metastasis stage, PLNR Positive lymph node ratio. Other Abbreviations as in Table 1 and Table 2